Nontargeted Metabolomic Profiling of Huo-Tan-Chu-Shi Decoction in the Treatment of Coronary Heart Disease with Phlegm-damp Syndrome

Figure 4

Serum metabolism profile alterations and metabolite-associated pathways. (a) The amount of differential metabolites among the experimental groups. (b) Heatmap of top 50 differential metabolites in the HTCSD vs Tanshi group. (c) Clusters of time sequence analysis of differential metabolites among the experimental groups. (d) The column chart of the top 20 KEGG pathways in the Tanshi vs control group. (e) The column chart of the top 20 KEGG pathways in the HTCSD vs Tanshi group. Abbreviations: HTCSD : Huo-Tan-Chu-Shi decoction.

(a)

(b)

(c)

(d)

(e)